"Gene Editing: Ethical Opportunities and Challenges of This Breakthrough Technology"
Hopkins Biotech Network (HBN) Affinity and Johns Hopkins Berman Bioethics Institute
The transformative potential of advances in science and technology is immense but does not come without a complement of unanswered and complex questions. Join Jeremy Sugarman, MD, MPH, MA, of the Johns Hopkins Berman Bioethics Institute, members of the Hopkins community and friends for a dynamic discussion about the breakthrough technology of Gene Editing.
To register please contact Becky Barnes, beckybarnes@jhu.edu
Jeremy Sugarman
Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Johns Hopkins Berman Institute of Bioethics. He is an internationally recognized leader in the field of biomedical ethics with particular expertise in the application of empirical methods and evidence-based standards for the evaluation and analysis of bioethical issues. His contributions to both medical ethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health and research oversight.
Dr. Sugarman is the author of over 275 articles, reviews and book chapters. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; andMethods in Medical Ethics). Dr. Sugarman is a contributing editor for IRB and is on the editorial boards of several academic journals.
Dr. Sugarman consults and speaks internationally on a range of issues related to bioethics. He has served as senior policy and research analyst for the White House Advisory Committee on Human Radiation Experiments, consultant to the National Bioethics Advisory Commission, and Senior Advisor to the Presidential Commission for the Study of Bioethical Issues. He also served on the Maryland Stem Cell Research Commission.
He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University and an Academic Icon of the University of Malaya.
Dr. Sugarman currently serves on the Scientific and Research Advisory Board for the Canadian Blood Service, the Ethics and Public Policy Committees of the International Society for Stem Cell Research, and the Board of Directors of PRIM&R (Public Responsibility in Medicine and Research). He is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee. In addition, he is chair of the Ethics Working Group of the HIV Prevention Trials Network.
Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation, Association of American Physicians, and the Institute of Medicine. He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center.